RPHM - Reneo Pharmaceuticals - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

RPHM is currently covered by 5 analysts with an average price target of $9.55. This is a potential upside of $7.88 (471.86%) from yesterday's end of day stock price of $1.67.

Reneo Pharmaceuticals's activity chart (see below) currently has 6 price targets and 17 ratings on display. The stock rating distribution of RPHM is 60% BUY and 40% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 5.56% with an average time for these price targets to be met of 2 days.

Highest price target for RPHM is $30, Lowest price target is $1, average price target is $9.55.

Most recent stock forecast was given by JOSEPH SCHWARTZ from LEERINK on 15-Dec-2023. First documented stock forecast 04-May-2021.

Best performing analysts who are covering RPHM - Reneo Pharmaceuticals:

Joseph Schwartz Yasmeen Rahimi Brian Skorney Mitchell Kapoor Eun Yang Gobind Singh

Currently out of the existing stock ratings of RPHM, 6 are a BUY (60%), 4 are a HOLD (40%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

1

$-0.68 (-40.48%)

15

4 months 11 days ago

0/3 (0%)

$-0.42 (-29.58%)

Hold

1.5

$-0.18 (-10.71%)

30

4 months 11 days ago

1/3 (33.33%)

$0.08 (5.63%)

12

Hold

1.8

$0.12 (7.14%)

24

4 months 11 days ago

0/2 (0%)

$0.38 (26.76%)

Hold

4

$2.32 (138.10%)

4 months 12 days ago

0/4 (0%)

$2.66 (198.51%)

Buy

30

$28.32 (1685.71%)

30

7 months 18 days ago

0/2 (0%)

$22.89 (321.94%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RPHM (Reneo Pharmaceuticals) average time for price targets to be met?

On average it took 2 days on average for the stock forecasts to be realized with a an average price target met ratio 5.56

Which analyst has the current highest performing score on RPHM (Reneo Pharmaceuticals) with a proven track record?

JOSEPH SCHWARTZ

Which analyst has the current lower performing score on RPHM (Reneo Pharmaceuticals) with a proven track record?

GOBIND SINGH

Which analyst has the most public recommendations on RPHM (Reneo Pharmaceuticals)?

Joseph Schwartz works at LEERINK and has 2 price targets and 5 ratings on RPHM

Which analyst is the currently most bullish on RPHM (Reneo Pharmaceuticals)?

Gobind Singh with highest potential upside - $28.32

Which analyst is the currently most reserved on RPHM (Reneo Pharmaceuticals)?

Joseph Schwartz with lowest potential downside - -$0.68

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?